Skip to main content
Thomas Heineman, MD, Otolaryngology (ENT), Cedar Rapids, IA

ThomasHeinemanMD

Otolaryngology (ENT) Cedar Rapids, IA

Laryngology & Voice Disorders, Otolaryngic Allergy, Rhinology & Paranasal Sinus Disease

Otolaryngologist

Dr. Heineman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Heineman's full profile

Already have an account?

  • Office

    202 10th St SE
    Cedar Rapids, IA 52403
    Phone+1 319-247-3010
    Fax+1 877-876-2384

Summary

  • I am a practicing otolaryngologist - head and neck surgeon treating patients with sinus disorders (rhinology), allergic disease, sleep apnea and sleep surgery, head and neck cancer, endocrine disorders including thyroid and parathyroid diseases, as well as voice and swallowing disorders. I strive to be an early adopter of biomedical technology both in the operating room and the clinic. I am the author of over 50 peer-reviewed publications and national and international presentations. Prior, I completed his surgery training at the University of California Los Angeles where he was involved in numerous research endeavors ranging from genomics of head and neck cancer to bioabsorbable sinus implants. In 2015, I completed a healthcare consulting internship at McKinsey and Company after the completion of medical school at Weill Cornell Medical College. I received biomedical research training at The Rockefeller University completing a prestigious year-long research fellowship in the genomics of head and neck cancer which was funded by the NIH. I am a member of the Academy of Otolaryngology-Head and neck surgery, as well as numerous other professional societies.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 2015 - 2020
  • UCLA
    UCLAResident Informatics Program, Clinical Informatics, 2016 - 2017
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Surgery, 2015 - 2016
  • Rockefeller University
    Rockefeller UniversityMedical Student Research Fellowship, 2014 - 2015
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2015, MD
  • University of Oxford
    University of OxfordFellowship, 2009 - 2010
  • University of Iowa
    University of IowaBA, Chemistry, Summa Cum Laude, 2006 - 2010

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 2019 - 2026
  • CA State Medical License
    CA State Medical License 2017 - 2021
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • The Arthur Palmur Prize for Efficiency in Otorhinolaryngology Weill Cornell Medical College, 2015
  • The Coryell Prize in Surgery Weill Cornell Medical College, 2015
  • The John Metcalf Polk Prize (Valedictorian) Weill Cornell Medical College, 2015
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Mutational Landscape of Cutaneous and Sinonasal Melanoma
    Heineman TE, St John M, Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2/15/2018
  • In silico analysis of KRAS mutations in thyroid cancer: From the computer to the bedside
    Heineman TE, St John M, Association of Southeast Asian Nations Otolaryngology Conference, Yangon, Myanmar (Burma), 11/24/2017
  • Triological best practice: When should surveillance imaging be performed after treatment of head and neck cancer?
    Heineman TE, Kuan EC, St John M., Triological Combined Sections Meeting, New Orleans, Louisiana, 1/18/2017
  • Join now to see all

Lectures

  • In silico analysis of NF2 gene missense mutations in NF2: From genotype to phenotype. 
    Boston, MA - 4/25/2015
  • Clinical and histologic characteristics of oncocytic thyroid cancer. 
    Boston, MA - 4/25/2015
  • In silico analysis of RET mutations in medullary thyroid cancer: From the computer to the bedside. 
    New York, NY - 7/26/2014
  • Join now to see all

Press Mentions

  • Oncolytics Biotech Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial by Investing.com
    Oncolytics Biotech Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial by Investing.comMay 25th, 2023
  • Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort
    Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer CohortNovember 14th, 2022
  • Objective Response Rate (ORR) and Clinical Benefit Rate (CBR) in GOBLET's PDAC Cohort (N=13) Were 69% and 85%, Respectively
    Objective Response Rate (ORR) and Clinical Benefit Rate (CBR) in GOBLET's PDAC Cohort (N=13) Were 69% and 85%, RespectivelyOctober 12th, 2022
  • Join now to see all

Committees

  • UCLA Representative, Section for Residents and Fellow of the American Academy of Otolaryngology 2017 - Present
  • Medical Student Representative, Weill Cornell Medical College Faculty General Council 2012 - 2015

Professional Memberships

Other Languages

  • French

Industry Relationships

  • Healthcare Consultant, McKinsey and Company2015 - 2015